MPH fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Medicure, Inc. is a pharmaceutical company, which engages in the research, clinical development, and commercialization of cardiovascular therapeutics. It focuses on marketing and distribution of acute care cardiovascular drug, Aggrastat; Zypitamag (pitavastatin) tablets; Sodium Nitroprusside injection. The company was founded by Albert D. Friesen on September 15, 1997 and is headquartered in Winnipeg, Canada.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
MPH does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company